Search

Showing "11155" results for ""

How does HIV make us sick?

Punching fog – how people with HIV are tackling stigma worldwide

GSK and Pfizer launch joint HIV venture, ViiV Healthcare

New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection

Circumcision protects gay men who have a 'preference' for insertive sex from HIV

Certain manifestations of stigma especially hurtful for people with HIV

Reassurance for HIV-positive women about short-term risk of bone loss

International donors must not retreat from commitment to HIV treatment scale-up, MSF warns

Multiple treatment failures occur less frequently but remain associated with high mortality rates in North American cohort

People with HIV providing high quality treatment support in community

Draft Ugandan HIV legislation undermines human rights

ART offer at antenatal clinics doubles uptake in Lusaka

Global cost of HIV treatment and prevention could reach $35 billion by 2031

Prevention a priority at European HIV conference

Blood rather than semen mode of HCV transmission in HIV-positive gay men

Most HIV/HBV co-infected patients in Europe have detectable HBV viral load

Multiple pregnancies a safe option for women with HIV

Protease inhibitor monotherapy as a maintenance regimen: are we edging towards acceptance?

Receive the latest HIV research and conference news

Showing "11155" results for ""

How does HIV make us sick?

Punching fog – how people with HIV are tackling stigma worldwide

GSK and Pfizer launch joint HIV venture, ViiV Healthcare

New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection

Circumcision protects gay men who have a 'preference' for insertive sex from HIV

Certain manifestations of stigma especially hurtful for people with HIV

Reassurance for HIV-positive women about short-term risk of bone loss

International donors must not retreat from commitment to HIV treatment scale-up, MSF warns

Multiple treatment failures occur less frequently but remain associated with high mortality rates in North American cohort

People with HIV providing high quality treatment support in community

Draft Ugandan HIV legislation undermines human rights

ART offer at antenatal clinics doubles uptake in Lusaka

Global cost of HIV treatment and prevention could reach $35 billion by 2031

Prevention a priority at European HIV conference

Blood rather than semen mode of HCV transmission in HIV-positive gay men

Most HIV/HBV co-infected patients in Europe have detectable HBV viral load

Multiple pregnancies a safe option for women with HIV

Protease inhibitor monotherapy as a maintenance regimen: are we edging towards acceptance?

Receive the latest HIV research and conference news